Promega Corp v. Life Tech, No. 13-1011 (Fed. Cir. Nov. 13, 2017)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

This case ret urns to us on remand from the Supreme Court. See Life Techs. Corp. v. Promega Corp. , 137 S. Ct. 734, 741 (2017) ( Promega II). Defendants -Appellants (collectively, Life) sought review of our decision in Promega Corp. v. Life Technologies Corp., 773 F.3d 1338 (Fed. Cir. 2014) ( Promega I), arguing , inter alia, that we erred in holding that a multicomponent product assem- bled overseas could infringe a United States patent under 35 U.S.C.